Skip to main content
. 2015 Mar 13;9(5):1895–1900. doi: 10.3892/etm.2015.2352

Table III.

DOR of the patients affected by different factors.

Factor Number of patients Median DOR (months) P-value
Bortezomib
  Yes 14 11 0.046
  No 12 4
Auto-SCT
  Yes  9 16 0.012
  No 17 4.5
Abnormality by FISH
  Yes 10 6 0.617
  No 16 9
EMP
  Yes 10 6.5 0.667
  No 16 9

DOR, duration of remission; auto-SCT, autologous stem cell transplantation; abnormality by FISH, one of t(4;14), t(14;16) or del17p abnormalities by FISH; FISH, fluorescence in situ hybridization; EMP, extramedullary plasmacytoma.